Milton L. Wainberg, M.D., is an Associate Clinical Professor of Psychiatry at Columbia University. He is a Latino research psychiatrist who is fluent in English, Spanish, and Portuguese and has been involved in HIV-related activities since the late 1980s. He has extensive clinical and teaching experience in HIV/AIDS and mental health issues. He is the Medical Director of the Columbia University HIV Mental Health Training Project (HRSA2H4AHA00071), a member of the APA Committee on AIDS, and the Chair of the Mental Health HIV Clinical Guidelines Committee, NYS Department of Health, AIDS Institute.
He conducts weekly in-service HIV-related trainings with HIV, mental health and substance abuse providers about clinical issues at the intersection of HIV, substance use/abuse and mental health, including prevention and treatment. He has worked to adapt HIV prevention interventions for South African psychiatric patients and written HIV-related policy for the South African mental health care system (OAR Supplement; R01MH58917; PI: Susser). He has been an investigator in NIAAA (R01AA11745; PI: Morgenstern) and NIDA (R01DA15971; PI: Morgenstern) RCT studies, participating in the design, development, and conduct of interventions simultaneously targeting sexual HIV risk behaviors and alcohol or drugs.
He is currently an investigator on a NIAAA study (R01AA014323; PI: Hasin) to reduce unsafe drinking in primary HIV care. Dr. Wainberg has conducted risk-reduction interventions to evaluate outcomes with both HIV-positive and at-risk populations: individuals with severe mental illness, hemophiliacs, adolescents, Latinos, and MSM. He has also developed and evaluated an intervention focusing on HIV prevention and increasing medical adherence for Latinos who are HIV-positive (CDCU22/CCU218529). Dr. Wainberg currently is the PI of an NIMH-funded project (R01MH65163) that, through an original adaptation model using evidence-based efficacious prevention interventions, developed a culturally appropriate HIV prevention intervention for people in Brazil with severe mental illness . He successfully applied for a competitive continuation to test the efficacy of this HIV prevention intervention. His research experience combines CBPR, formative work, risk behavior and substance use/abuse assessment, intervention adaptation, development, piloting and efficacy-testing, capacity building and training, leading research teams with investigators from different disciplines, and expertise in collaborative research work that focuses on enhancing real-world clinical treatment.